A recent study published in the journal Science Translational MedicineUS researchers designed a bivalent coronavirus disease 2019 (COVID-19) vaccine on a messenger ribonucleic acid (mRNA) platform....
The rapid pandemic of a new coronavirus, namely severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to the coronavirus disease 2019 (COVID-19) pandemic that has...
In a recent study posted on bioRxiv* Preprint server, researchers evaluated the efficiency of lipid nanoparticles against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). study: Delivery...
Recent articles posted on bioRxiv* The preprint server analyzed a multivalent messenger ribonucleic acid (mRNA) -lipid nanoparticle (LNP) vaccine construct against a specific β-coronavirus (β-CoV). study:...
In a recent study posted on bioRxiv* Preprint server, researchers have developed a mucosal vaccine for coronavirus disease 2019 (COVID-19) based on bacteriophage. study: Bacteriophage-based highly...
Messenger RNA (mRNA) vaccines are a prime example of a promising field of nanomedicine.However, advances in the design and application of nanoparticles as efficient delivery media...
Recent Comments